Enlin Jin - JD Health CEO Director
JDHIY Stock | USD 3.81 0.00 0.00% |
Insider
Enlin Jin is CEO Director of JD Health International
Age | 42 |
Web | https://ir.jdhealth.com |
JD Health Management Efficiency
JD Health's management efficiency ratios could be used to measure how well JD Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
R Harris | AMN Healthcare Services | 66 | |
Sylvia TrentAdams | AMN Healthcare Services | 55 | |
LLB BECON | Ramsay Health Care | N/A | |
Brian Levinkind | WashTec AG | 57 | |
Blake Curd | Medical Facilities | N/A | |
David Hung | Sienna Senior Living | N/A | |
Puneet Khanna | CareRx | N/A | |
Mark Lugowski | Sienna Senior Living | N/A | |
William May | Medical Facilities | N/A | |
Ryan Stempfle | CareRx | N/A | |
Shane Sabatino | WashTec AG | N/A | |
David Murphy | CareRx | N/A | |
Jorge Caballero | AMN Healthcare Services | 64 | |
BSc BSc | WashTec AG | 48 | |
Teri Fontenot | AMN Healthcare Services | 67 | |
Stephen Roy | Sienna Senior Living | N/A | |
David Tenwick | Regional Health Properties | 86 | |
Carolyn Kenny | AMN Healthcare Services | N/A | |
Tonya McMorris | Regional Health Properties | N/A | |
Kelly Hibbins | Ramsay Health Care | N/A | |
Andrew Wearne | Ramsay Health Care | N/A |
Management Performance
Return On Equity | -0.0097 | |||
Return On Asset | -0.0099 |
JD Health International Leadership Team
Elected by the shareholders, the JD Health's board of directors comprises two types of representatives: JD Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of JDHIY. The board's role is to monitor JD Health's management team and ensure that shareholders' interests are well served. JD Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, JD Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
JDHIY Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is JD Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.0097 | |||
Return On Asset | -0.0099 | |||
Profit Margin | (0.01) % | |||
Operating Margin | (0.02) % | |||
Current Valuation | 29.92 B | |||
Shares Outstanding | 3.18 B | |||
Price To Book | 4.59 X | |||
Price To Sales | 0.84 X | |||
Revenue | 30.68 B | |||
Gross Profit | 7.2 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.NVDA | NVIDIA | |
CRESY | Cresud SACIF y | |
GOOG | Alphabet Inc Class C |
Additional Tools for JDHIY Pink Sheet Analysis
When running JD Health's price analysis, check to measure JD Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy JD Health is operating at the current time. Most of JD Health's value examination focuses on studying past and present price action to predict the probability of JD Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move JD Health's price. Additionally, you may evaluate how the addition of JD Health to your portfolios can decrease your overall portfolio volatility.